Alliance Pharma Plc (APH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 178,836 | 180,680 | 167,416 | 163,207 | 129,801 |
| Cost of Goods | 69,550 | 75,661 | 65,733 | 53,757 | 46,985 |
| Gross Profit | 109,286 | 105,019 | 101,683 | 109,450 | 82,816 |
| Operating Expenses | 80,871 | 64,209 | 72,880 | 78,882 | 53,143 |
| Operating Income | 28,415 | 40,810 | 28,803 | 30,568 | 29,673 |
| Interest Expense | 8,629 | 9,530 | 4,785 | 3,007 | 2,076 |
| Other Income | -34,246 | -80,080 | -18,810 | -9,404 | -14,581 |
| Pre-tax Income | -14,460 | -48,800 | 5,208 | 18,157 | 13,016 |
| Income Tax | -3,731 | -15,664 | 4,272 | 10,838 | 4,989 |
| Net Income Continuous | -10,729 | -33,136 | 936 | 7,319 | 8,027 |
| Net Income | $-10,729 | $-33,136 | $936 | $7,319 | $8,027 |
| EPS Basic Total Ops | -0.02 | -0.06 | 0.00 | 0.01 | 0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.06 | 0.00 | 0.01 | 0.02 |
| EPS Diluted Total Ops | -0.02 | -0.06 | 0.00 | 0.01 | 0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.06 | 0.00 | 0.01 | 0.02 |
| EBITDA(a) | $3,864 | $-28,944 | $20,753 | $37,419 | $36,057 |